Featured MNV Articles:
More articles: 1 2 3 4 5 6 7 next »
|Oversold Conditions For Acadia Pharmaceuticals (ACAD)
Wednesday, May 10, 12:04 PM ET, by Market News Video Staff
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...
5 Joel Greenblatt Holdings Attracting Short Sellers
Wednesday, May 10, 1:11 PM ET, by Market News Video Staff
An examination of the most recent short interest data revealed these five Joel Greenblatt stocks ...
Intrexon Breaks Above 200-Day Moving Average - Bullish for XON
Monday, May 15, 11:19 AM ET, by Market News Video Staff
In trading on Monday, shares of Intrexon Corp (XON) crossed above their 200 day moving ...
JUNO Makes Notable Cross Below Critical Moving Average
Wednesday, May 17, 4:57 PM ET, by Market News Video Staff
In trading on Wednesday, shares of Juno Therapeutics Inc (JUNO) crossed below their 200 day ...
Investors Grab ALNY Even Cheaper Than Its Secondary Stock Offering
Friday, May 26, 10:01 AM ET, by Market News Video Staff
Looking back to 2 days ago, Alnylam Pharmaceuticals Inc (ALNY) priced a 5,000,000 share secondary ...
Myriad Genetics Enters Oversold Territory (MYGN)
By Dividend Channel Staff, Thursday, April 20, 2:10 PM ET
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.
In trading on Thursday, shares of Myriad Genetics, Inc. (NASDAQ:MYGN) entered into oversold territory, hitting an RSI reading of 27.2, after changing hands as low as $17.50 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 46.1. A bullish investor could look at MYGN's 27.2 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of MYGN shares:
Looking at the chart above, MYGN's low point in its 52 week range is $15.15 per share, with $38.72 as the 52 week high point — that compares with a last trade of $17.63. Find out what 9 other oversold stocks you need to know about »
According to the ETF Finder at ETF Channel, MYGN makes up 3.51% of the First Trust NYSE Arca Biotechnology Index Fund ETF (AMEX:FBT) which is trading up by about 0.2% on the day Thursday.
See what other ETFs contain MYGN »
See what other stocks are held by FBT »
Can your brain be trained to become a chart-predicting wizard? Click here to find out
This Article's Word Cloud: